April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Identification of Retinal Vascular Markers of Early-Stage Diabetic Retinopathy
Author Affiliations & Notes
  • Mette Ladefoged
    Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark
    Department of Diabetes Complications Biology, Novo Nordisk A/S, Maaloev, Denmark
  • Christopher Mayer
    Department of Diabetes Complications Biology, Novo Nordisk A/S, Maaloev, Denmark
  • Nanna Junker
    Department of Diabetes Complications Biology, Novo Nordisk A/S, Maaloev, Denmark
  • Toke Bek
    Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark
  • Footnotes
    Commercial Relationships Mette Ladefoged, Novo Nordisk A/S (E); Christopher Mayer, Novo Nordisk A/S (E); Nanna Junker, Novo Nordisk A/S (E); Toke Bek, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4923. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mette Ladefoged, Christopher Mayer, Nanna Junker, Toke Bek; Identification of Retinal Vascular Markers of Early-Stage Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4923.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Diabetic retinopathy (DR) is the leading cause of vision loss among the working age population in the Western world. The pathogenesis involves changes in metabolic parameters affecting the retinal vasculature leading to pericyte loss, endothelial dysfunction and vascular permeability. The development of new treatment modalities requires a better understanding of molecular and biochemical changes that can only be studied in animal models. The purpose of the present study was to identify early gene expression patterns that can act as markers of retinal vascular disturbances in experimentally induced diabetes in mice.

Methods: SV129 mice were induced with diabetes using streptozotocin (double intermediate dose; 125mg/kg) or vehicle (controls). After 15 weeks, animals were sacrificed and eyes enucleated and snap-frozen. Retinal vessels were isolated by hypotonic lysis. Total RNA was isolated using the RNeasy micro kit according to the manufacturer’s instructions. Differences in gene expression of selected markers were analyzed using TaqMan Array Cards containing 44 selected retinal vascular markers, including mural cell and tight junction markers.

Results: 15 weeks of streptozotocin-induced diabetes resulted in a significant change in gene expression of a number of the examined markers, including downregulation of the mural cell marker, NG-2, and the tight junction protein, ZO-1.

Conclusions: The results demonstrate that after 15 weeks of diabetes mellitus changes in genes coding for specific retinal vascular markers can be observed in the SV129 mouse strain. Normalization of these markers may be a potential proxy for the testing of new drugs aimed at preventing the development of diabetic retinopathy.

Keywords: 499 diabetic retinopathy • 436 blood supply • 533 gene/expression  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×